155 related articles for article (PubMed ID: 9717163)
1. [The activity of the macrolides on Haemophilus influenzae: a critical review].
Perea EJ
Med Clin (Barc); 1998 Feb; 110 Suppl 1():60-4. PubMed ID: 9717163
[No Abstract] [Full Text] [Related]
2. [Comparison of the activity of different macrolides on strains of Haemophilus influenzae].
Ramírez de Arellano JA; Perea EJ
Rev Esp Quimioter; 2000 Sep; 13(3):291-6. PubMed ID: 11086280
[TBL] [Abstract][Full Text] [Related]
3. Characterization of macrolide resistance genes in Haemophilus influenzae isolated from children with cystic fibrosis.
Roberts MC; Soge OO; No DB
J Antimicrob Chemother; 2011 Jan; 66(1):100-4. PubMed ID: 21081549
[TBL] [Abstract][Full Text] [Related]
4. Prevalence of anti-microbial resistance among respiratory isolates of Haemophilus influenzae.
Puri J; Talwar V; Juneja M; Agarwal KN; Gupta HC
Indian Pediatr; 1999 Oct; 36(10):1029-32. PubMed ID: 10745313
[No Abstract] [Full Text] [Related]
5. In vitro activity of cefotaxime, ceftizoxime, cefmenoxime, and latamoxef in comparison with other beta-lactam antibiotics against recent clinical isolates of Haemophilus influenzae and Haemophilus parainfluenzae.
Kawakami Y; Okimura Y; Horiuchi N; Kanai M
Microbiol Immunol; 1982; 26(7):617-21. PubMed ID: 6290854
[No Abstract] [Full Text] [Related]
6. [Haemophilus influenzae in 1980: clinical, microbiological and therapeutic aspects. A review].
Bergeron MG; Gagné JM; Déry P; Gauvreau L
Union Med Can; 1980 Apr; 109(4):499-506. PubMed ID: 7006179
[No Abstract] [Full Text] [Related]
7. A scientific perspective on macrolide susceptibility. Conclusion.
Grimm H
Int J Antimicrob Agents; 1999 Mar; 11 Suppl 1():S33-4. PubMed ID: 10204637
[No Abstract] [Full Text] [Related]
8. Drug-resistant H influenzae: a growing geriatric problem.
Gleckman RA; Roth RM
Geriatrics; 1984 Sep; 39(9):51-3, 56-8, 60. PubMed ID: 6332044
[No Abstract] [Full Text] [Related]
9. [Drug sensitivity of haemophilus influenzae type b:n].
Nissinen A; Takala AK; Eskola J
Duodecim; 1989; 105(21):1722-7. PubMed ID: 2583027
[No Abstract] [Full Text] [Related]
10. Activity of gemifloxacin against Streptococcus pneumoniae and Haemophilus influenzae.
Morrissey I; Tillotson G
J Antimicrob Chemother; 2004 Feb; 53(2):144-8. PubMed ID: 14729748
[TBL] [Abstract][Full Text] [Related]
11. Invasive Haemophilus influenzae type f disease.
Nitta DM; Jackson MA; Burry VF; Olson LC
Pediatr Infect Dis J; 1995 Feb; 14(2):157-60. PubMed ID: 7746705
[No Abstract] [Full Text] [Related]
12. In vitro activity of tigecycline against ampicillin-resistant Haemophilus influenzae isolates.
Betriu C; Gómez M; Rodríguez-Avial I; Culebras E; Picazo JJ
J Antimicrob Chemother; 2005 May; 55(5):809-10. PubMed ID: 15790670
[No Abstract] [Full Text] [Related]
13. Antimicrobial susceptibilities of Haemophilus influenzae in Hong Kong.
French GL; Ling J; Oo HK; Hui YW
J Chemother; 1989 Jul; 1(4 Suppl):299-300. PubMed ID: 16312409
[No Abstract] [Full Text] [Related]
14. Antimicrobial resistance in Haemophilus influenzae: how can we prevent the inevitable? Commentary on antimicrobial resistance in H. influenzae based on data from the TARGETed surveillance program.
Rennie RP; Ibrahim KH
Clin Infect Dis; 2005 Aug; 41 Suppl 4():S234-8. PubMed ID: 16032558
[TBL] [Abstract][Full Text] [Related]
15. Antimicrobial resistance of Streptococcus pneumoniae and Haemophilus influenzae in Sao Paulo, Brazil from 1996 to 2000.
Koeth LM; Felmingham D; Jacobs MR; Rossi F
Int J Antimicrob Agents; 2004 Apr; 23(4):356-61. PubMed ID: 15081084
[TBL] [Abstract][Full Text] [Related]
16. In-vitro susceptibility of Haemophilus influenzae to loracarbef (LY 163892) and other oral antibiotics. Collaborative Study Group on Pediatric Infectious Disease in Lombardy.
Garlaschi ML; Colombo R; Varotto F; Conio F; Rusconi F; Sideri S; Gagliardi L; Sala A; Arghittu M
J Chemother; 1991 Jan; 3 Suppl 1():47-50. PubMed ID: 12043716
[TBL] [Abstract][Full Text] [Related]
17. Comparative in vitro evaluation of dirithromycin tested against recent clinical isolates of Haemophilus influenzae, Moraxella catarrhalis, and Streptococcus pneumoniae, including effects of medium supplements and test conditions on MIC results.
Biedenbach DJ; Jones RN; Lewis MT; Croco MA; Barrett MS
Diagn Microbiol Infect Dis; 1999 Apr; 33(4):275-82. PubMed ID: 10212755
[TBL] [Abstract][Full Text] [Related]
18. Invasive Haemophilus influenzae isolates with decreased levofloxacin susceptibility in Hong Kong.
Ho PL; Mak GC; Tse CW; Chow KH; Cheung CH
J Antimicrob Chemother; 2006 Feb; 57(2):366. PubMed ID: 16387750
[No Abstract] [Full Text] [Related]
19. [In vitro resistance rates of Streptococcus pneumoniae and Haemophilus influenzae clinical isolates to the antibiotics used in therapy].
Uncu H; Colakoğlu S; Turunç T; Demiroğlu YZ; Arslan H
Mikrobiyol Bul; 2007 Jul; 41(3):441-6. PubMed ID: 17933256
[TBL] [Abstract][Full Text] [Related]
20. Italian Haemophilus influenzae surveillance results.
Russo G; Covelli I; Filadoro F; Fontana R; La Placa M; Martinetto P; Mastroeni P; Renzini G; Satta G; Schito GC; Varaldo PE
J Chemother; 1989 Jul; 1(4 Suppl):36-8. PubMed ID: 16312294
[No Abstract] [Full Text] [Related]
[Next] [New Search]
